- Home
- Oncology Drugs Market

Global Oncology Drugs Market Analysis
- Published Date: December, 2022 | Report ID: CLS-1895 | No of pages: 225 | Format:
Global Oncology Drugs Market Executive Summary
The increased developments in the pharmaceutical industry in the past few years, continue to make cancer more treatable. The growing prevalence of cancer led to a rise in demand for cancer drugs across the globe. The oncology drugs that are majorly used in the diagnosis of cancer depend upon the stages of the progression. Various types of cancer such as blood cancer, skin cancer, lung cancer, breast cancer, gastrointestinal cancer, and bone cancer among others can be treated by oncology drugs.
Market Size and Key Findings
The Global Oncology Drugs Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Oncology Drugs Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
The growth of the oncology drugs market is driven by an increase in the prevalence of cancer disease and the rise in the incidence of various cancer conditions, an increase in the popularity of advanced therapies, and a surge in the geriatric population worldwide.
Market Restraints
The high cost involved in new drug development coupled with the threat of failure & adverse effects associated with cancer drug therapies poses to restrain the growth of oncology.
Competitive Landscape
Key Players
Major players in Oncology Drugs Market are F. Hoffmann-La Roche AG, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Johnson & Johnson, Pfizer Inc., AstraZeneca, AbbVie Inc., Astellas Pharma Inc.
TABLE OF CONTENT
1. Report Description of the Global Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Oncology Drugs Market Executive Summary
2.1 Global Oncology Drugs Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key Findings
3. Market Dynamics of Global Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Oncology Drugs Market Segmentation
4.1 By Drug Class
4.1.1 Cytotoxic drugs
4.1.2 Targeted drugs
4.1.3 Hormonal drugs
4.1.4 Others
4.2 By Therapy
4.2.1 Chemotherapy
4.2.2 Targeted therapy
4.2.3 Immunotherapy
4.3 By Indication
4.4 By Dosage Form
4.4.1 Solid
4.4.2 Liquid
4.4.3 Injectable
4.5 By Distribution Channel
4.5.1 Hospital Pharmacies
4.5.2 Retail Pharmacies
4.5.3 Online Pharmacies
4.5.4 Others
5. Global Oncology Drugs Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Oncology Drugs Market
9. Factors Driving Future Growth
9.1 New Trends and Development Global Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Oncology Drugs Market Segmentation
By Drug class
- Cytotoxic drugs
- Alkylating agents
- Antimetabolites
- Others
- Targeted drugs
- Monoclonal antibodies
- Others
- Hormonal drugs
- Others
By Therapy
- Chemotherapy
- Targeted therapy
- Immunotherapy
By Indication
- Lung cancer
- Stomach cancer
- Colorectal cancer
- Breast cancer
- Prostate cancer
- Others
By Dosage form
- Solid
- Tablets
- Capsules
- Liquid
- Injectable
- Prefilled syringes
- Others
By Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.